Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000927016-99-001259
Filing Date
1999-03-31
Accepted
1999-03-31 00:00:00
Documents
6
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 128003
2 AGREEMENT AND PLAN OF REORGANIZATION EX-2 155321
3 LETTER AGREEMENT DATED OCTOBER 23, 1998 EX-10.14 5969
4 LEASE TERMINATION AGREEMENT DATED NOVEMBER 6, 1998 EX-10.15 3361
5 CONSENT OF ERNST & YOUNG LLP EX-23 666
6 FINANCIAL DATA SCHEDULE EX-27 2324
  Complete submission text file 0000927016-99-001259.txt   297668
Mailing Address 738 MAIN STREET SUITE 431 WALTHAM MA 02451
Business Address 738 MAIN STREET SUITE 431 WALTHAM MA 02451 6173741200
TRANSCEND THERAPEUTICS INC (Filer) CIK: 0001020910 (see all company filings)

EIN.: 043174575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-22383 | Film No.: 99583095
SIC: 2836 Biological Products, (No Diagnostic Substances)